Funder: SHIRE PHARMACEUTICALS IBERIA SL
date_range Duration: from 27 June 2019 to 27 June 2022 (36 months) Finished
euro 36,300.00 EUR

Of International (non-EU) scope. It has been granted under a regime of Direct grant.

Call: (SHIRE PHARMACEUTICALS IBERIA SL)

Researchers